NO853066L - Fremgansmaate til fremstilling av 3-karbonyl-1-aminoalkyl-1h-indoler. - Google Patents

Fremgansmaate til fremstilling av 3-karbonyl-1-aminoalkyl-1h-indoler.

Info

Publication number
NO853066L
NO853066L NO853066A NO853066A NO853066L NO 853066 L NO853066 L NO 853066L NO 853066 A NO853066 A NO 853066A NO 853066 A NO853066 A NO 853066A NO 853066 L NO853066 L NO 853066L
Authority
NO
Norway
Prior art keywords
indoles
aminoalkyl
carbonyl
procedure
preparation
Prior art date
Application number
NO853066A
Other languages
English (en)
Other versions
NO169067C (no
NO169067B (no
Inventor
Malcolm Rice Bell
Original Assignee
Sterling Drug Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterling Drug Inc filed Critical Sterling Drug Inc
Publication of NO853066L publication Critical patent/NO853066L/no
Priority to NO903305A priority Critical patent/NO903305D0/no
Priority to NO903306A priority patent/NO903306D0/no
Priority to NO903304A priority patent/NO903304D0/no
Publication of NO169067B publication Critical patent/NO169067B/no
Publication of NO169067C publication Critical patent/NO169067C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/08Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO853066A 1984-08-06 1985-08-02 Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-karbonyl-1-aminoalkyl-1h-indoler, og mellomprodukter NO169067C (no)

Priority Applications (3)

Application Number Priority Date Filing Date Title
NO903305A NO903305D0 (no) 1984-08-06 1990-07-25 Fremgangsmaate for fremstilling av 3-karbonyl-1-aminoalkyl-1h-indoler.
NO903306A NO903306D0 (no) 1984-08-06 1990-07-25 Fremgangsmaate for fremstilling av 3-karbonyl-1-aminoalkyl-1h-indoler.
NO903304A NO903304D0 (no) 1984-08-06 1990-07-25 Fremgangsmaate for fremstilling av 3-karbonyl-1-aminoalkyl-1h-indoler.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63793184A 1984-08-06 1984-08-06

Publications (3)

Publication Number Publication Date
NO853066L true NO853066L (no) 1986-02-07
NO169067B NO169067B (no) 1992-01-27
NO169067C NO169067C (no) 1992-05-06

Family

ID=24557949

Family Applications (1)

Application Number Title Priority Date Filing Date
NO853066A NO169067C (no) 1984-08-06 1985-08-02 Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-karbonyl-1-aminoalkyl-1h-indoler, og mellomprodukter

Country Status (20)

Country Link
EP (1) EP0171037B1 (no)
JP (1) JPH0670010B2 (no)
KR (1) KR870000548B1 (no)
AR (1) AR244665A1 (no)
AT (1) ATE77371T1 (no)
AU (1) AU574817B2 (no)
DE (1) DE3586224T2 (no)
DK (1) DK170279B1 (no)
ES (5) ES8609246A1 (no)
FI (1) FI852973L (no)
GR (1) GR851937B (no)
IE (1) IE57863B1 (no)
IL (1) IL75966A (no)
MX (4) MX160612A (no)
MY (1) MY101186A (no)
NO (1) NO169067C (no)
NZ (3) NZ212953A (no)
PH (2) PH23498A (no)
PT (1) PT80919B (no)
ZA (1) ZA855923B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8623819D0 (en) * 1986-10-03 1986-11-05 Glaxo Group Ltd Heterocyclic compounds
US4840950A (en) * 1987-02-11 1989-06-20 Sterling Drug Inc. 4-arylcarbonyl-1-[(4-morpholinyl)-lower-alkyl]-1H-indoles
US5068234A (en) * 1990-02-26 1991-11-26 Sterling Drug Inc. 3-arylcarbonyl-1-(c-attached-n-heteryl)-1h-indoles
GB9011335D0 (en) * 1990-05-21 1990-07-11 Fujisawa Pharmaceutical Co Indolebutyric acid derivatives and process for preparation thereof
US5312829A (en) * 1990-05-21 1994-05-17 Fujisawa Pharmaceutical Co., Ltd. Indole derivatives
GB9204365D0 (en) * 1992-02-28 1992-04-08 Pfizer Ltd Indoles
TW270114B (no) * 1993-10-22 1996-02-11 Hoffmann La Roche
US5486525A (en) * 1993-12-16 1996-01-23 Abbott Laboratories Platelet activating factor antagonists: imidazopyridine indoles
CA2382116A1 (en) 1999-08-26 2001-03-08 Fujisawa Pharmaceutical Co., Ltd. Process for the preparation of indole derivatives or salts thereof
JP6493786B2 (ja) * 2015-01-06 2019-04-03 パナソニックIpマネジメント株式会社 免疫原、それを用いた抗体の製造方法、及び、そのモノクローナル抗体
JP6435505B2 (ja) * 2015-01-13 2018-12-12 パナソニックIpマネジメント株式会社 化合物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3238215A (en) * 1963-10-17 1966-03-01 Sterling Drug Inc 1-[(3-, 2-, and 1-indolyl)-lower-alkyl-, lower-alkenyl-, and lower-alkynyl]piperidines
US3217011A (en) * 1965-05-07 1965-11-09 Sterling Drug Inc 1-(indolyglyoxalyl)-piperidines
US3489429A (en) * 1967-12-18 1970-01-13 American Home Prod 1-loweralkanoyl-3-(2-substituted ethyl)indoles
GB1374414A (en) * 1972-06-12 1974-11-20 Sterling Drug Inc 1-acyl-3-amino-alkyl-indoles and their preparation
GB1436771A (en) * 1973-02-16 1976-05-26 Labaz Indole derivatives and process for preparing the same
FR2354766A1 (fr) * 1976-06-17 1978-01-13 Labaz Derives n-aminoalkyles d'indole et procedes pour les preparer
IL74251A (en) * 1984-02-07 1990-01-18 Pfizer 1,3-disubstituted oxindoles and analgesic and antiinflammatory compositions comprising them

Also Published As

Publication number Publication date
EP0171037A3 (en) 1987-08-26
NZ212953A (en) 1990-02-26
AR244665A1 (es) 1993-11-30
ES8800902A1 (es) 1987-12-01
NZ225466A (en) 1990-02-26
KR860001805A (ko) 1986-03-22
DK354485D0 (da) 1985-08-05
NO169067C (no) 1992-05-06
ES8801203A1 (es) 1987-12-16
DK354485A (da) 1986-02-07
AU574817B2 (en) 1988-07-14
JPH0670010B2 (ja) 1994-09-07
PT80919A (en) 1985-09-01
GR851937B (no) 1985-12-05
MX14432A (es) 1993-08-01
IL75966A0 (en) 1985-12-31
EP0171037A2 (en) 1986-02-12
KR870000548B1 (ko) 1987-03-18
ES552909A0 (es) 1987-12-01
MY101186A (en) 1991-07-31
ES8609246A1 (es) 1986-07-16
ES552912A0 (es) 1987-10-16
IE851930L (en) 1986-02-06
MX14431A (es) 1993-08-01
ES545894A0 (es) 1986-07-16
PH23498A (en) 1989-08-16
ES552911A0 (es) 1987-12-01
AU4576485A (en) 1986-02-13
FI852973A0 (fi) 1985-08-01
FI852973L (fi) 1986-02-07
JPS6147463A (ja) 1986-03-07
PT80919B (pt) 1987-09-30
ATE77371T1 (de) 1992-07-15
NZ225467A (en) 1990-02-26
ES552910A0 (es) 1987-12-16
DK170279B1 (da) 1995-07-24
DE3586224D1 (de) 1992-07-23
MX14429A (es) 1993-09-01
ES8800149A1 (es) 1987-10-16
EP0171037B1 (en) 1992-06-17
ES8800901A1 (es) 1987-12-01
DE3586224T2 (de) 1993-01-28
MX160612A (es) 1990-03-28
ZA855923B (en) 1986-03-26
NO169067B (no) 1992-01-27
IL75966A (en) 1989-08-15
IE57863B1 (en) 1993-05-05
PH25360A (en) 1991-05-13

Similar Documents

Publication Publication Date Title
NO822722L (no) Fremgangsmaate til fremstilling av benzazepin-2-oner.
NO874764D0 (no) Fremgangsmaate for fremstilling av 2-aminopurinderivater.
FI852516A0 (fi) Anordning foer dosering av tillvaext befraemjande aemnen.
NO167515C (no) Fremgangsmaate for fremstilling av basissmoereoljer.
NO160263C (no) Analogifremgangsmaate til fremstilling av antibiotisk acetylerytromycistearat.
NO872356L (no) Fremgangsmaate til fremstilling av monokaliumfosfat.
NO158136C (no) Fremgangsmaate til fremstilling av tiadiazolderivater.
NO861486L (no) Fremgangsmaate til fremstilling av fluorerte benzyltriazolforbindelser.
NO855067L (no) Fremgangsmaate for fremstilling av n-formyl-alfa-aspartyl-fenylalanin.
NO853066L (no) Fremgansmaate til fremstilling av 3-karbonyl-1-aminoalkyl-1h-indoler.
NO851310L (no) Stereospesifikk fremgangsmaate til fremstilling av acetonoksyazetidinon.
NO851920L (no) Fremgangsmaate for fremstilling av imidazo-rifamycin-derivater.
NO853172L (no) Fremgangsmaate for fremstilling av tixotrope vaskemidler.
NO845071L (no) Fremgangsmaate til fremstilling av ferromangan.
NO159080C (no) Fremgangsmaate til fremstilling av 2,4-diklor-5-fluor-benzosyre.
NO165637C (no) Fremgangsmaate for fremstilling av etoksylert lignitt.
NO161353C (no) Fremgangsmaate for fremstilling av pastiller.
NO863769D0 (no) Fremgangsmaate for fremstilling av 4-hydroksy-2-oksopyrrolin-1-yl-acetamid.
NO880106D0 (no) Fremgangsmaate til fremstilling av kalknitrogen.
NO864087D0 (no) Fremgangsmaate for fremstilling av aroylthiazoloner.
NO161911C (no) Fremgangsmaate for fremstilling av sulfonater.
NO166709C (no) Fremgangsmaate for fremstilling av akrylamider.
NO863604D0 (no) Fremgangsmaate til fremstilling av ferroborlegeringer.
NO851319L (no) Fremgangsmaate for fremstilling av eburnanderivater.
NO821874L (no) Fremgangsmaate for fremstilling av fenoletere.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees